Research programme: indolinone derivatives - SUGEN

Drug Profile

Research programme: indolinone derivatives - SUGEN

Alternative Names: Indolinone derivatives research programme - SUGEN; SU 5614; SU 6577; SU 6663; SU-4984

Latest Information Update: 29 Feb 2008

Price : $50

At a glance

  • Originator SUGEN
  • Class Small molecules
  • Mechanism of Action Proto oncogene protein c-kit inhibitors; Type 1 fibroblast growth factor receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Cancer

Most Recent Events

  • 19 Oct 2000 Preclinical development for Cancer in USA (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top